Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Health Economics for Noninvasive Coronary Fractional Flow Reserve Measurement Technology

NCT05593120 is registered in ClinicalTrials.gov with Shenzhen Raysight Intelligent Medical Technology Co., Ltd. as lead sponsor.

NCT NCT05593120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05593120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Health Economics for Noninvasive Coronary Fractional Flow Reserve Measurement Technology
Lead sponsor
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
June 29, 2022
Completion date
December 30, 2022
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease